Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Glaxo Wellcome receives approval in Germany for Flixotide in COPD

Oct. 13, 1999

News from ERS: tiotropium prevents methacholine-induced bronchoconstriction in asthmatics

Oct. 13, 1999

PDE3 inhibitor olprinone is an effective bronchodilator in asthma patients

Oct. 13, 1999

DHA: a new treatment for CF on the horizon?

Oct. 13, 1999

Positive phase I/II reported for Nuvance at European meeting

Oct. 13, 1999

Sheffield and Elan establish licensing agreement to develop respiratory products

Oct. 12, 1999

Sch-55700 prevents a variety of eosinophilic responses in animal models

Oct. 7, 1999

PKC, cytokine inhibitors in development at AstraZeneca

Oct. 7, 1999

AstraZeneca receives FDA approval of Rhinocort Aqua Nasal Spray

Oct. 7, 1999

Nikken Chemicals prepares PDE4 inhibitors useful for allergic and inflammatory disorders

Oct. 6, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...